MellingMedical and CellTivity Scientific have entered into a strategic partnership to supply the latter’s Van Gogh Microscopy System across the US federal healthcare system.
Under the arrangement, MellingMedical will distribute the cancer diagnostic technology to healthcare facilities serving active-duty military personnel, veterans, and their families.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The platform is a US Food and Drug Administration (FDA) Class I in vitro diagnostic (IVD) that uses Dynamic Cell Imaging (DCI) technology.
According to MellingMedical, the system enables clinicians to examine freshly excised biopsy specimens in real time by digitally recording metabolic and intracellular activity up to 150µm beneath the surface of the tissue.
Because the optical assessment requires neither cutting nor staining, 100% of the sample remains intact and preserved for subsequent molecular analysis and formal pathology.
MellingMedical founder and CEO Chris Melling said: “CellTivity’s track record of engineering high-quality, innovative diagnostic workflow solutions makes them an ideal ally for serving federal healthcare providers.
“Their specialised focus on cutting-edge technologies like the Van Gogh system will provide federal healthcare clinicians with the tools they need to enhance diagnostic confidence, maximise tissue sufficiency for next-generation sequencing, and deliver timely, optimal patient care.”
The commercial agreement allows CellTivity Scientific to deploy its point-of-care detection tool through MellingMedical’s federal contracting network.
MellingMedical operates as a Small Business Administration (SBA)-verified service-disabled veteran-owned small business (SDVOSB), holding a Medical Equipment and Surgical Federal Supply Schedule (Med/Surg), a Pharmaceutical Schedule, and electronic catalogue (ECAT) capabilities.
Its distribution channels cover 95 Department of Defense (DoD) Medical Facilities, 172 Veterans Affairs (VA) Medical Centers, and 1,138 VA Outpatient Clinics.
The network also supplies seven VA Consolidated Mail Outpatient Pharmacies (VA CMOPs) and the Department of Health and Human Services (HHS), which encompasses the Centers for Disease Control and Prevention (CDC) and Indian Health Service (IHS).
By digitally measuring metabolic activity at the point of care, the system is intended to guide intraprocedural tissue sampling, mitigating biopsy assessment delays and diagnostic inaccuracies across federal facilities.
